NO872586L - FremgangsmŸte for fremstilling av et rekombinant, konjugert protein. - Google Patents

FremgangsmŸte for fremstilling av et rekombinant, konjugert protein.

Info

Publication number
NO872586L
NO872586L NO872586A NO872586A NO872586L NO 872586 L NO872586 L NO 872586L NO 872586 A NO872586 A NO 872586A NO 872586 A NO872586 A NO 872586A NO 872586 L NO872586 L NO 872586L
Authority
NO
Norway
Prior art keywords
recombinant
preparing
procedure
conjugated protein
conjugated
Prior art date
Application number
NO872586A
Other languages
English (en)
Norwegian (no)
Other versions
NO872586D0 (no
Inventor
Anthony Arthur Holder
Michael James Lockyer
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO872586D0 publication Critical patent/NO872586D0/no
Publication of NO872586L publication Critical patent/NO872586L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO872586A 1986-06-20 1987-06-19 FremgangsmŸte for fremstilling av et rekombinant, konjugert protein. NO872586L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868615068A GB8615068D0 (en) 1986-06-20 1986-06-20 Vaccines

Publications (2)

Publication Number Publication Date
NO872586D0 NO872586D0 (no) 1987-06-19
NO872586L true NO872586L (no) 1987-12-21

Family

ID=10599794

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872586A NO872586L (no) 1986-06-20 1987-06-19 FremgangsmŸte for fremstilling av et rekombinant, konjugert protein.

Country Status (12)

Country Link
EP (1) EP0250261A1 (da)
JP (1) JPS63503512A (da)
AU (2) AU7542287A (da)
DK (1) DK313687A (da)
FI (1) FI872735A (da)
GB (1) GB8615068D0 (da)
NO (1) NO872586L (da)
NZ (1) NZ220777A (da)
PH (1) PH25860A (da)
WO (1) WO1987007908A1 (da)
ZA (1) ZA874454B (da)
ZW (1) ZW11387A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002757A1 (en) * 1986-10-17 1988-04-21 Saramane Pty. Ltd.; Hybrid proteins or polypeptides
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same
CA2037151A1 (en) * 1990-03-23 1991-09-24 F. Hoffmann-La Roche Ag Plasmodium sporozoite antigen
EP1105487A1 (en) 1998-08-21 2001-06-13 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services Recombinant multivalent malarial vaccine against plasmodium falciparum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
AU584881B2 (en) * 1984-02-21 1989-06-08 British Technology Group Limited Improvements in or relating to the production of malaria vaccines
AU606042B2 (en) * 1985-12-24 1991-01-31 Saramane Pty Ltd Asexual blood stage antigens of plasmodium falciparum

Also Published As

Publication number Publication date
AU604711B2 (en) 1991-01-03
FI872735A0 (fi) 1987-06-18
WO1987007908A1 (en) 1987-12-30
GB8615068D0 (en) 1986-07-23
EP0250261A1 (en) 1987-12-23
AU7542287A (en) 1988-01-12
NO872586D0 (no) 1987-06-19
DK313687A (da) 1987-12-21
ZW11387A1 (en) 1989-01-25
DK313687D0 (da) 1987-06-19
ZA874454B (en) 1989-01-25
PH25860A (en) 1991-12-02
AU7453687A (en) 1988-01-07
JPS63503512A (ja) 1988-12-22
FI872735A (fi) 1987-12-21
NZ220777A (en) 1990-12-21

Similar Documents

Publication Publication Date Title
NO870668D0 (no) Fremgangsmaate for gjenvinning av mikrobielt fremstilt rekombinant.
NO881044D0 (no) Fremgangsmaate for fremstilling av en tiazepinforbindelse.
FI872594A0 (fi) Cementprodukter, vilka innehaoller ytbehandlade oorganiska partiklar.
NO863871D0 (no) Fremgangsmaate for fremstilling av en kjoetterstatning.
NO904797L (no) Roerkrave.
FI863993A0 (fi) Foerfarande foer maetning av egenskaper hos formbara material, saerskilt plastiska och reologiska egenskaper.
NO880473D0 (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner.
NO881384L (no) Peptider.
NO885108L (no) Peptider.
FI872267A (fi) Stabila, vattenhaltiga suspensionskoncentratkompositioner.
NO881548L (no) Genteknologisk fremgangsmaate for fremstilling av polypeptider.
NO875038D0 (no) Konjugert vaksine.
IT1237508B (it) Procedimento per preparare n-fosfonometilglicina.
DE3586765D1 (de) Immunogenische hav-peptide.
NO872586L (no) FremgangsmŸte for fremstilling av et rekombinant, konjugert protein.
NO871759D0 (no) Fremgangsmaate for fremstilling av sucralfat-preparater.
FI872598A0 (fi) N-1h-tetrazol-5-yl-2-tiofen-, n-1h -tetrazol-5-yl-2-pyrrol- och n-1h-tetrazol-5-yl-2-furankarboxamider.
NO864695D0 (no) Fremgangsmaate for fremstilling av 2,2[-bi-1h-imidazoler.
NO870828L (no) FremgangsmŸte for fremstilling av biskarbamater.
IT1206792B (it) Procedimento per preparare una mercaptoacilprolina.
NO904034L (no) Fremgangsmaate for fremstilling av 1-etylfenoksatiin-10,10-dioksyd.
NO872624D0 (no) Fremgangsmaate for fremstilling av 3,7-dihydro-3-n-propyl-1h-purin-2,6-dion.
NO872386D0 (no) Peptider.
FI871432A (fi) Foerkopplingsdrossel, speciellt foer gasurladdningslampor.
NO864307D0 (no) Fremgangsmaate for fremstilling av 5-heterocycliske-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.